The Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center was established in 2010 to analyze the healthcare systems through which cancer care is delivered. Our goal is to develop evidence-based policy approaches that promote high-quality care and improve patient outcomes.
Members of the Center collaborate on independent, empirical research and analysis that is pragmatic and nonpartisan. We work on a wide range of cancer types and issues, and have a diverse body of expertise that draws on Memorial Sloan Kettering's capabilities.
Cost of Cancer Drugs
Cost of one month of treatment for an adult for each new cancer drug approved by the United States Food and Drug Administration, based on Medicare reimbursement rates and by year of drug approval.
Learn more about the research »